share_log

复星医药关于控股子公司获药品临床试验批准的公告

Announcement of Fosun Pharmaceutical on the approval of its holding subsidiary for drug clinical trials

Sensex a share ·  May 15

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.